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In this retrospective study, we investigated the independent effects of white matter
hyperintensities (WMH) and hippocampal atrophy on cognitive functions in a broad
sample of patients seen in a memory clinic. To ensure generalizability, these associations
were examined irrespective of diagnosis and with minimal exclusion criteria. Next to
these independent effects, interactions between WMH and hippocampal atrophy were
examined. Between January 2006 and September 2011 a total of 500 patients visited the
memory clinic, 397 of whom were included. Magnetic resonance images of 397 patients
were visually analyzed for WMH, medial temporal atrophy (MTA), and global atrophy.
We evaluated the association of WMH and MTA with the following cognitive domains:
global cognition, episodic memory, working memory, executive function and psychomotor
speed. Main effects and interaction effects were examined by means of correlation and
regression analyses. In the regression analyses, we controlled for potential confounding
effects of global atrophy. The correlational results revealed that WMH were associated
with global cognition, executive function and psychomotor speed, whereas a trend was
found for episodic memory. MTA was associated with all these four cognitive domains;
an additional trend was observed for working memory. Hierarchical regression analyses
revealed main independent effects of MTA for episodic memory, executive function,
psychomotor speed and global cognition;WMHwere only associatedwith global cognition.
The interaction between MTA and WMH was significant for episodic memory only. This
study demonstrates that predominantly MTA is an independent predictor not only for
memory function, with which is it classically associated, but also for global cognition and
executive function.Taken together, MTA may be an important correlate of cognitive deficits
found in people attending the memory clinic.
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INTRODUCTION
Medial temporal atrophy (MTA), and in particular hippocam-
pal atrophy, is one of the earliest changes seen in the brains
of patients with Alzheimer’s Disease (AD), and its presence has
proven to be a sensitive marker for the diagnosis of AD (Braak
and Braak, 1991). MTA is also an early marker of AD on mag-
netic resonance imaging (MRI). Longitudinal studies found that
MTA was already present in preclinical AD and in this preclini-
cal stage the rate of hippocampal volume loss also predicted the
progression to AD dementia (Twamley et al., 2006). Studies of the
relationship between morphological and cognitive measures of
AD have demonstrated that MTA, especially of the hippocam-
pus, correlates with episodic memory impairment in AD (de
Leon et al., 1997). Other cognitive abilities are affected as the
neuropathological changes of AD spread from limbic structures
to neocortical association areas (Braak and Braak, 1998). White
matter hyperintensities (WMH) are also commonly observed in
patients with AD, although their clinical relevance is not well
understood (Barber et al., 1999). Some studies have reported that
AD patients with WMH have slower cognitive processing speed
and greater executive dysfunction thanADpatients withoutWMH
(Amar et al., 1996; Libon et al., 1998). Other studies found no sub-
stantial neuropsychological differences between patients with or
without WMH (DeCarli et al., 1996; Doody et al., 1998; Bartrés-
Faz et al., 2001). Compared to the contradictory results regarding
the correlations between WMH and cognitive dysfunction, stud-
ies examining MTA have shown a more consistent association
with cognitive deficits, particularly with memory. For example,
MTA correlates with impairments of verbal memory in elderly
with cognitive dysfunction (Kohler, 1994; Laakso et al., 1995).
Even though there are many studies on cognitive impairments
related to either MTA or WMH, only a few studies have assessed
the independent effects of MTA and WMH concurrently on cog-
nitive functioning. In one study on AD patients, gray matter
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volume and WMH were independently related to overall cog-
nitive decline (Stout et al., 1996). A recent study examined the
independent effects of WMH and MTA on various cognitive
functions in AD patients (Shim et al., 2011), and found that the
cognitive deficit profiles related to WMH were rather dissimilar
from those associated with MTA. WMH were more related to
attention and executive functioning, while MTA was more associ-
ated with visuospatial function, language, and memory. Another
important finding was that interactions exist between WMH and
MTA with regard to the effects on cognitive functions, suggest-
ing that they synergistically contribute to cognitive impairment in
AD.
Although these studies point toward associations of bothWMH
and MTA with cognitive function, several factors limit interpreta-
tion of these results. Most studies examined the effects of WMH
and MTA in isolation, not taking into account the strong asso-
ciation that exists between these MRI correlates. Furthermore,
the majority of these studies were performed in strictly defined
groups of patients, e.g., only AD patients, in tertiary referral
centers, which likely leads to referral bias. Additionally, these
studies used extensive exclusion criteria, thereby risking selection
bias. It is therefore currently unknown whether these findings
can be generalized to a broad sample of patients seen in gen-
eral memory clinics. Finally, most of these studies used global
measures of cognitive dysfunction, lacking a detailed investi-
gation of memory or executive function with well-defined test
batteries.
Thus, the first goal of this study was to investigate if there is
an independent effect of WMH and MTA on various cognitive
deficits in a broad sample of patients seen in a memory clinic,
regardless of diagnosis and without the use of extensive exclusion
criteria. The second goal of this study was to investigate if there
is an interaction effect of WMH and MTA on various cognitive
deficits in this patient sample.
MATERIALS AND METHODS
PATIENTS
This retrospective study focused on patients who presented with
memory complaints to the memory clinic at Zutphen Medical
Center, Zutphen, The Netherlands, a general hospital. The major-
ity of the patients were referred by the general practitioner. All had
memory problems confirmed by a caregiver. The study population
consisted of 500 consecutive patients who had been referred to the
Zutphen memory clinic between November 2004 and September
2011. All patients underwent an elaborate work-up consisting of
a general physical and neurological examination, blood screen-
ing, structural neuroimaging consisting of magnetic resonance
imaging (MRI), and electroencephalogram as well as an exten-
sive neuropsychological examination. Patients were excluded if
they presented with a hearing impairment or visual impairment,
or were too aphasic to complete the neuropsychological assess-
ment. Patients who underwent CT-scan instead of MRI, because
of claustrophobia or metal particles, were excluded from the
sample (n = 30); MRI-data was furthermore not complete for
six patients. In addition, neuropsychological test results were
not available (due to communication difficulties resulting from
Dutch not being the patient’s mother tongue, n = 2; severe
aphasia, n = 11; or non-compliance, n = 7) or the test pro-
tocol differed systematically because of a younger age (n = 47)
(see Figure 1). Hence, data of 397 patients were used for the
analyses. The following variables were recorded: age at study
enrolment, sex, level of education, vascular risk factors includ-
ing hypertension, diabetes mellitus, cardiac disease and a history
of stroke. Diagnoses were made in multidisciplinary consensus
meeting according to the DSM-IV. At present, cerebrospinal fluid
(CSF) assessment is not part of the routine diagnostic work-up
for dementia in the Netherlands. However, in case no consensus
was reached regarding the diagnosis, CSF was collected from the
patient and taken into account in the diagnostic process. The fol-
lowing diagnoses were established: dementia due to Alzheimer’s
disease (n = 98), mild cognitive impairment (n = 75), vascu-
lar dementia (n = 27), frontotemporal dementia (n = 11), Lewy
body dementia (n = 6), Parkinsonism disorders (n = 16), stroke
(n = 8), vascular cognitive impairment (n = 5), neurological
disorder (e.g., encephalitis; n = 11), dementia (n = 2), other
neurodegenerative disorder (e.g., progressive aphasia; n = 6),
Korsakoff ’s syndrome (n = 3), or a psychiatric disorder (e.g.,
depression; n = 29). For 40 patients, evidence of cognitive impair-
ment was established, but no diagnosis could yet be made. One
patient revealed mental retardation and one was diagnosed with
post-operative cognitive impairment. Finally, 58 people did not
show any sign of cognitive impairment and, hence, received no
FIGURE 1 | Flowchart of the included patients.
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diagnosis. The level of education was classified using the system
of Verhage (1964), ranging from 1 (less then primary school) to 7
(university degree). Characteristics of these patients are presented
in Table 1.
NEUROPSYCHOLOGICAL ASSESSMENT
The neuropsychological test battery was designed to screen the
majority of cognitive functions, including measures of orienta-
tion, memory, attention, language, executive functioning, and
psychomotor speed. Two experienced neuropsychologists com-
pleted all neuropsychological examinations, and were blinded
to all medical information at time of assessment. All tests were
administered during a single session, with a fixed order of admin-
istration designed to minimize the introduction of any new verbal
stimuli during delay periods for verbal memory tests. Testing
was done on the same day as MRI scanning as part of the rou-
tine screening process. Tests were employed tapping the following
domains: global cognition, working memory, episodic memory,
executive function, and psychomotor speed. Multiple tests were
used to assess each domain, with the exception of psychomotor
speed, which was measured with a single test.
Global cognition was assessed with the cognitive screening test
(CST) and the mini mental state examination (MMSE: Folstein
et al., 1975). The CST is a twenty-item orientation question-
naire that is commonly used to evaluate cognitive impairment
(De Graaf and Deelman, 1991). Severity of cognitive impairment
was assessed using the MMSE, a short screening instrument for
cognitive functioning.
Forworkingmemory, the digit span forward andbackward tests
were used (WAIS-III, digit span, Wechsler, 1987), which require
patients to repeat series of numbers increasing in length in the
same or reversed order.
For episodic memory, the visual association test (VAT; Linde-
boom et al., 2002), the 8-word test and a prose recall test were
used. The VAT material consists of six association cards showing
two interacting objects that are not commonly connected in daily
life (for example an ape holding an umbrella), and six cue cards
showing only one of the objects (e.g., the ape). At first, patients
are shown the six cue cards with one of the objects, followed by
the association cards with the previously seen object plus an inter-
acting object. Patients are asked to name the object on the cue
cards, and subsequently to name each pair of interacting objects
Table 1 | Characteristics of the patients.
Patients
Age 75.82 (8.06)
Education 4.00 (1–7)
Sex (M/F) 175/222
WMH 1.50 (0–3)
MTA 1.00 (0–4)
GA 1.00 (0–3)
Mean (±SD) is presented for age together with median (range) for education,
WMH, MTA, and GA. Frequencies are presented for sex distribution.
on the association cards. Recall is tested immediately following
presentation, by showing the cue cards again and asking what
object is missing. One point is awarded if the response is suffi-
ciently clear to distinguish the target object from the other objects
used in the test; the series is then repeated (total score 0–12). In
the prose recall test (Lezak et al., 2004), a short 20-item story is
read to the patient, who is instructed to repeat as many items
as possible immediately after presentation and after an interval
of 10–15 min. Episodic Memory was furthermore assessed with
the eight-word test of the Amsterdam dementia-screening test (de
Jonghe et al., 1994), which includes a list of eight words to be
recalled immediately after each of the five verbal presentations,
as well as after a 10-min delay by means of a free recall and a
recognition test.
Executive functioning was measured by using the trail mak-
ing test part A and B (TMT; Reitan, 1958), the frontal assessment
battery (FAB; Dubois et al., 2000), and the Meander task of the
Amsterdam dementia-screening test. The TMT-A consists of 25
encircled numbers positioned randomly on a sheet of paper. The
patient is required to subsequently connect these numbers. The
more complex part B requires patients to alternate between let-
ters and numbers (e.g., 1-A-2-B-3-C-. . .) and was used to evaluate
cognitive flexibility. For both conditions, the time required for
completion is recorded; the TMT-B ratio score (TMT-B/TMT-A)
was used for the analyses. The FAB is a short cognitive and
behavioral test battery consisting of six subtest: (1) similarities
(conceptualization); (2) lexical fluency (mental flexibility); (3)
motor series (programming); (4) conflicting instructions (sen-
sitivity to interference); (5) go/no go (inhibition control); and
(6) prehension behavior (environmental autonomy). Each sub-
test was rated from 0 to 3. The total score ranges from 0 to 18
(Takagi et al., 2002). The Meander, a figure of two alternating
elements which the subject has to continue, is sensitive to perse-
verations characteristic for frontal disorders. Finally, the TMT-A
completion time was included as a measure of psychomotor
speed.
Ongoing efforts to improve the neuropsychological screening
procedure resulted in a slightly varying content of the neuropsy-
chological battery over the years. The following neuropsychologi-
cal tests were applied since the establishment of the memory clinic
in November 2004: TMTA+B; the eight-word test; the CST; the
MMSE; theProse recall test; theDigit SpanForward andBackward,
and the Meander. In subsequent years the VAT (June 2005) and
FAB (August 2007) were added to the neuropsychological battery.
In addition, some patients could not complete all tests. As a result
of both factors the available data varied per test: 253 patients com-
pleted the TMT-A, 169 patients completed the TMT-B, 371 the
eight-word test, 397 the CST, 396 the MMSE, 326 the Digit Span
Forward and Backward, 391 the Meander, 350 the Prose recall test,
378 the VAT, and 338 the FAB.
MRI PROTOCOL
Brain MRIs were obtained with a 1.5 Tesla GE-Signa Horizon LX
scanner. The same scanner was used for all patients. A standard-
ized imaging protocol consisting of whole brain axial and coronal
fluid-attenuated inversion recovery (FLAIR; TR 10,000 ms, TE
160 ms), sagittal T1 (repetition time TR 300 ms, TE 4 ms) and
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axial T2-weighted (TR 6500 ms, TE 105 ms) images was used. The
slice thickness for all images was 5 mm with a 2 mm gap.
The protocol of MRI acquisition for this study included the
T1-weigthed axial, the T2-weigthed axial, the fluid-attenuated
inversion recovery (FLAIR), and the T1-weigthed coronal images.
The assessment ofWMH,MTA,and global atrophywas performed
by two experienced independent observers, blinded to the clinical
diagnoses.
On the T2-weigthed axial and FLAIR images, we evaluated the
severity of WMH according to the modified criteria of Fazekas,
using a 0–3 rating scale (Fazekas et al., 1987). T1-weigthed coro-
nal images were employed to rate MTA, using a 5-point rating
scale (0–4) which is based on the width of the coronal fissure and
the temporal horn and the height of the hippocampal formation
(Scheltens et al., 1992). Global atrophy score is the mean score
for cortical atrophy throughout the complete cerebrum, and was
rated on a 4-point rating scale (0–3; Scheltens et al., 1997). These
scores were based on the sulcal width and gyral thinning in the
frontal, temporal and parieto-occipital lobes. For rating global
atrophy the T1-weigthed axial, the T2-weigthed axial, FLAIR, and
the T1-weigthed coronal images were used.
STATISTICAL ANALYSES
Statistical analyses were performed using the SPSS software pack-
age version 19. For all analyses, the statistical significance was
set at p < 0.05. To reduce the number of statistical analyses,
cognitive domain scores were calculated. For this, the sepa-
rate neuropsychological test scores were z-standardized. Next,
average scores were calculated resulting in the following cogni-
tive domains: global cognition (based on the MMSE and the
CST-20), episodic memory (based on the VAT, 8-word test–
immediate and delayed recall, prose immediate and delayed
recall), working memory (based on digit span forward and back-
ward) and executive function (based on TMT-B ratio score,
Meander, FAB). Psychomotor speed was based on the individ-
ual TMT-A score. In case of missing neuropsychological test
scores, the available test scores were used to calculate the specific
domain.
First, Spearman rank correlations were calculated to explore
the main associations between the cognitive functions, WMH
and MTA. Next, to determine the unique contributions of
WMH and MTA and the interaction between these two neu-
roimaging variables, the following steps were taken. WMH were
dichotomized into no or mild WMH (score <2) and moder-
ate to severe WMH (score ≥2); a similar approach was used to
dichotomize MTA (no or mild MTA, score <2; moderate to severe
MTA, score ≥2). Hierarchical multiple linear regression analy-
ses were performed to examine the contribution of WMH and
MTA to neuropsychological test performance. Global atrophy,
dichotomized into no or mild atrophy (score <2) and moder-
ate to severe atrophy (score ≥2), was entered first, to ascertain
that effects of MTA and WMH reflect more than simply under-
lying global atrophy. Next, main effects of WMH and MTA were
entered. Finally, the interaction between WMH and MTA was
entered to explore whether the combination of severe WMH
with severe MTA was related to worse neuropsychological test
performance.
In addition to the interaction betweenWMH and MTA, similar
hierarchical multiple linear regression analyses were performed
for the interaction between WMH and GA and between MTA and
GA. These analyses were performed separately for each interaction
term in order to reduce multicollinearity among the predictors.
RESULTS
No or mild WMH and MTA was present in 120 patients, moder-
ate/severe MTA combined with no/mild WMH was present in 58
patients,moderate/severeWMHwithno/mildMTAwas present in
78 patients, whereas 141 patients had combined moderate/severe
MTA and WMH.
CORRELATION BETWEEN COGNITIVE PERFORMANCE, WMH AND MTA
The result of the correlational analysis is presented in Table 2.
WMH were associated with global cognition, executive function,
and psychomotor speed, but there was only a trend (p = 0.07) for
episodic memory. MTA was associated with these four cognitive
domains; an additional trend was observed between MTA and
working memory (p = 0.07).
MAIN AND INTERACTION EFFECTS OF WMH AND MTA
The cognitive domain scores were not normally distributed;
we therefore examined which type of transformation (square
root, logarithmic, or rank-based inverse normal transforma-
tion) resulted in the optimal skewness and kurtosis values; the
goal here was to use the minimum amount of transforma-
tion (Osborne, 2002). Consequently, square root transformation
was used for the working memory domain, natural logarith-
mic for the global cognition domain and the psychomotor
speed score, and inverse normalization for the executive func-
tion and memory domains. Hierarchical regression analyses (see
Table 3) revealed significant main effects of MTA for memory,
executive function, psychomotor speed, and global cognition;
WMH were only associated with global cognition. The inter-
action between MTA and WMH was significant for memory
only.
Further inspection of this interaction effect while controlling
for age (see Figure 2) revealed that memory performance was
lowest in the group with severe MTA, followed by the group
with combined severe MTA and WMH. Post hoc comparisons
(with Bonferroni correction) revealed that compared to group
with no or mild WMH and MTA, performance was worse in the
moderate/severe MTA group (p < 0.001) and in the group with
Table 2 | Correlations between the cognitive domain scores,WMH and
MTA.
Global
cognition
Episodic
memory
Working
memory
Executive
function
Psychomotor
speed
WMH −0.176∗∗ −0.091 −0.017 −0.115∗ −0.232∗∗
MTA −0.237∗∗ −0.202∗∗ −0.101 −0.212∗∗ −0.287∗∗
Spearman rank correlations were calculated. A higher cognitive domain score
represents better performance. MTA: medial temporal lobe atrophy;WMH: white
matter hyperintensities. ∗p < 0.05, ∗∗p < 0.01.
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Table 3 | Main and interaction effects ofWMH, GA, and MTA in relation to the different cognitive domain scores.
Global cognition Episodic memory Working memory Executive function Psychomotor speed
Step 1
GA (β) −0.140∗∗ −0.108∗ −0.062 −0.187∗∗∗ −0.199∗∗
Step 2
GA (β) −0.077 −0.060 −0.046 −0.154∗∗ −0.096
MTA (β) −0.140∗∗ −0.153∗∗ −0.050 −0.116∗ −0.238∗∗∗
WMH (β) −0.081 −0.007 −0.001 0.012 −0.072
Step 3
GA(β) −0.080 −0.064 −0.045 −0.157∗∗ −0.096
MTA (β) −0.242∗∗∗ −0.292∗∗∗ −0.150 −0.219∗∗ −0.202∗
WMH (β) −0.165∗ −0.121 −0.086 −0.073 −0.045
MTAxWMH (β) 0.175 0.238∗ 0.173 0.177 −0.060
Step 3
GA(β) −0.090 −0.268∗∗ −0.165 −0.348∗∗∗ −0.059
MTA (β) −0.140∗∗ −0.148∗∗ −0.043 −0.112∗ −0.240∗∗
WMH (β) −0.086 −0.086 −0.047 −0.062 −0.059
GAxWMH (β) 0.017 0.275∗∗ 0.157 0.256∗ −0.048
Step 3
GA(β) −0.171 −0.243∗∗ −0.164 −0.255∗∗ −0.010
MTA (β) −0.179∗∗ −0.229∗∗∗ −0.096 −0.158∗ −0.206∗∗
WMH (β) −0.078 −0.002 0.005 0.014 −0.077
MTAxGA (β) 0.128 0.251∗ 0.158 0.137 −0.115
Results of the hierarchical regression analyses with forced entry. For each cognitive domain, three analyses were performed, one for each interaction term. A higher
cognitive score represents better task performance. GA: global atrophy; MTA: medial temporal atrophy; WMH: white matter hyperintensities. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001.
concurrent moderate/severe MTA andWMH (p< 0.05). No other
between-group comparisons were significant.
Hierarchical regression analyses on the interaction effect
betweenWMH and GA (see Table 3) revealed significant effects of
this interaction term for episodic memory and executive function.
Further inspection of these interactions, while controlling for
age, revealed that memory performance was lowest in the group
with severeGA, followedby the groupwith combined severeWMH
and GA. Post hoc comparisons (Bonferroni correction) revealed
that compared to the group with no or mild WMH and GA, per-
formance was worse in the moderate/severe GA group (p < 0.001)
and in the group with concurrent moderate/severe WMH and GA
(p< 0.05). No other between-group comparisonswere significant.
For executive functioning, performance was lowest in the group
with moderate/severe GA only, followed by the group with mod-
erate/severe GA and WMH. Post hoc comparisons (Bonferroni
correction) revealed that performance was significantly compro-
mised in themoderate/severeGAonly group compared to both the
no/mild WMH and GA group (p < 0.01) and the moderate/severe
WMH only group (p < 0.05).
Finally, the interaction effect of MTAandGAwas significant for
episodic memory only (see Table 3). Compared to the group with
no/mild MTA and GA, episodic memory performance was signif-
icantly worse in the moderate/severe MTA only group (p < 0.05)
and in the moderate/severe GA only group (p < 0.01) (Bonferroni
correction). No further significant differences were found.
DISCUSSION
In thepresent study,we examined the independent effects ofWMH
and MTA on various cognitive functions in a broad sample of
patients seen in a memory clinic, irrespective of diagnosis and
without the use of extensive exclusion criteria. Furthermore, we
investigated the interaction effect of WMH and MTA on various
cognitive functions in this patient sample. The results indicated
that MTA was the most important predictor of cognitive func-
tion. Main effects of WMH were limited to global cognition, and
significant interaction effects were limited to episodic memory.
However, in contrast to our expectations, it was not the combi-
nation of moderate to severe MTA and WMH that resulted in the
worst episodic memory performance, but the presence of moder-
ate to severe MTA without concurrent moderate to severe WMH.
This again substantiates the importance of MTA for cognitive
test performance. Taken together, the results indicate that MTA
is not only associated with episodic memory functioning, as has
been found in previous studies, but is also an important corre-
late of more prefrontally mediated functions, including executive
function, psychomotor speed and working memory. Disorders
in these functions are often clinically interpreted as evidence of
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FIGURE 2 | Episodic memory performance of the different MTA andWMH severity groups. Higher cognitive scores represent better performance. MTA:
medial temporal atrophy;WMH: white matter hyperintensities.
symptomatic cerebrovascular disease, but the current study shows
that these functions may be strongly associated with MTA.
WHITE MATTER DISEASE
Despite extensive research over the last decades, the clinical sig-
nificance of white matter disease is still a matter of debate. In
their review on the relation between WMH and cognitive func-
tion, Schmidt et al. (2011) concluded that large inter-individual
variability exists with regard to the clinical correlates of WMH.
They presumed that one of the reasons for large inter-individual
variability in the clinical presentation of subjects withWMH is the
complexity of the association. Several factors, such as cognitive
reserve and associated loss of brain volume have been identified as
mediators between white matter damage and clinical findings. In
the current study, support for the clinical relevance ofWMH is also
limited. Only for global cognition did MTA and WMH contribute
independently to poor task performance.
Although the inter-individual variability limits the interpre-
tation of WMH in terms of clinical implications of these MRI
findings at an individual level, there is clear evidence that WMH
relate to cognitive functioning at a group level. Recent studies show
that WMH are associated with deficits in executive functioning,
often affecting daily functioning, by impairing erroneous goal for-
mation, planning and organizing (Bracco et al., 2005; Prins et al.,
2005; Pohjasvaara et al., 2007; Rabbitt et al., 2007; Tiehuis et al.,
2008; Geerlings et al., 2009; Mungas et al., 2009). Beyond execu-
tive functioning,WMH seem to have a subtle but noticeable effect
on other cognitive domains as well, such as speed of information
processing (Prins et al., 2005; Sachdev et al., 2005; van den Heuvel
et al., 2006; Delano-Wood et al., 2008; Tiehuis et al., 2008) and
memory (Mosley et al., 2005; Au et al., 2006; Chen et al., 2006;
Pohjasvaara et al., 2007; Baune et al., 2009; Geerlings et al., 2009).
In accordance with these studies we found that WMH were
significantly correlated with global cognition, executive func-
tion, psychomotor speed and marginally with episodic memory.
Nonetheless, when the contributions of MTA and global cortical
atrophy were taken into account, the relationship between WMH
and cognition remained significant for global cognition only.
HIPPOCAMPAL ATROPHY
With regard to hippocampal atrophy, MTA measures have shown
a relative consistent association with cognitive impairment. For
example, our findings are in accordance with previous studies that
found that MTA is significantly associated with episodic mem-
ory (Kohler, 1994; Laakso et al., 1995; Tulving and Markowitsch,
1998; Stout et al., 1999; Shimet al., 2011). Other cognitive domains
have been less exclusively examined in relation to MTA. Only a
handful of studies have examined the effect of hippocampal atro-
phy on executive dysfunction as a non-memory disorder. Recent
studies showed a significant relation between hippocampal atro-
phy and executive dysfunction (Nagata et al., 2010; Oosterman
et al., 2012). This finding was confirmed in the present study, in
that we found that MTA was also associated with impairments of
executive function, as well as global cognitive status (Laakso et al.,
1995) and psychomotor speed. In addition, the extent to which the
effects of MTA are independent of, and extend beyond, the influ-
ence of WMH and global atrophy has been addressed only in few
studies.
Frontiers in Aging Neuroscience www.frontiersin.org May 2014 | Volume 6 | Article 98 | 6
Overdorp et al. MRI correlates of cognition
DISENTANGLING MTA, GLOBAL ATROPHY, AND WMH CONTRIBUTIONS
TO COGNITIVE DYSFUNCTION
Medial temporal atrophy scores are consistently associated with
WMH (Appel et al., 2009) and both may be independently associ-
ated with cognitive task performance (Stout et al., 1996). However,
because MTA has been traditionally linked to memory, and WMH
to executive function, the frequent coexistence of MTA and WMH
may automatically lead to attribution of all executive dysfunc-
tion to WMH and of memory-related dysfunction to MTA. A
recent study that examined the independent effects of WMH and
MTA on cognition in AD patients (Shim et al., 2011), found that
MTA was mostly associated with language and memory, whereas
WMH were associated with attention and frontal executive func-
tioning. In this study, however, global atrophy was not taken into
account. How this may affect interpretation was shown in a study
where WMH were no longer associated with severity of cognitive
impairment, after controlling for atrophy (Hirono et al., 2000).
The present study confirms this finding: after confounding effects
of global atrophy and MTA were controlled for, the unique con-
tribution of WMH to cognitive test performance was minimal.
On the other hand, the strong effect of MTA on memory, execu-
tive function, psychomotor speed and global cognition, extended
beyond potential confounding effects of WMH and global
atrophy.
RELEVANCE
These data are important for our understanding of which dis-
eases or pathological processes underlie cognitive impairment and
dementia in the aging population. Although AD is considered the
most commoncauseof dementia, the commonview is that demen-
tia in older age is multifactorial, with important contributions of
Alzheimer pathology and cerebrovascular disease. Clinically,many
such patients are diagnosed as“mixed dementia,” a combination of
AD and vascular dementia. This is driven by the high prevalence
of WMH on MRI in the aging population. The contribution of
these WMH to the observed cognitive dysfunction, however, may
be overestimated, as our study indicates. If MTA and global atro-
phy underlie not only memory, but also executive dysfunction, the
clinical impact of WMH may be much smaller than is currently
believed. This may also have consequences for preventive strate-
gies. The effect of prevention of WMH may be overestimated if
in fact the cognitive impairment attributed to WMH is caused by
MTA. For example, optimizing vascular care inAD has been found
to be effective in reducing WMH, but had no effect on cognitive
function (Richard et al., 2009, 2010).
The present study has some strength and limitations. The
strengths of this current study are the large number of subjects
evaluated and the detailed neuropsychological, clinical, and MRI
investigation in the same subject, gathered within 1 week of exam-
ination. Furthermore, the patients enrolled in this study were all
first-time referrals by the general practitioner to a local community
hospital-based memory clinic. We minimized exclusion criteria to
ascertain that the study sample is representative of the population
seen in this memory clinic. This is in contrast to the majority of
studies that have examined the effects of WMH and MTA on cog-
nitive function that were conducted in strictly defined patients in
tertiary or research settings, using extensive exclusion criteria. Our
study is the first to show that these findings also apply to a broad
sample of patients seen in a general memory clinic. In addition, in
contrast to many previous studies, we controlled for global atro-
phy when examining the unique contributions of WMH and MTA
to cognitive task performance.
Despite these strengths, the present study also has some limi-
tations. Although each test was chosen to measure functioning in
a specific cognitive domain, there is in fact considerable overlap
between cognitive domains. Therefore, reduced performance on
a specific test may be caused by impairment in several cognitive
domains. For example, the TMT part B is essentially a test for
complex psychomotor speed and executive functioning. However,
due to the complex test instructions, it also places a substantial
demand on memory.
Another potential limitation is that in the current study only a
single measure of psychomotor speed was available, which is cru-
cial to take into account since no significant relationship of this
cognitive measures with WMH was found. White matter tracts
support the functioning of the cognitive processes that reside
within different cortical and subcortical brain areas. Consequently,
WMH may result in inefficient neural activity that could lead to,
in the first instance, cognitive slowing rather than cognitive dys-
function. van den Heuvel et al. (2006) found that the volume of
periventricular WMH at baseline was longitudinally associated
with more time needed to complete the Stroop test, indicating
reduced mental processing speed. Additionally, the progression
in periventricular hyperintensity volume paralleled the decline of
cognitive slowing. Their set of cognitive tests were somewhat dif-
ferent from the set we used; nevertheless, both sets included a
test that has often been used to measure speed of mental process-
ing, the Trail Making Test A. In addition, the strong association
between this measure and MTA, together with the fact that the
significant correlation between WMH and psychomotor speed
disappeared when concurrently considering MTA and GA, indi-
cates that, also for psychomotor speed, the role of WMH may be
questionable.
Furthermore, the use of biomarkers to support the presence
of AD pathophysiological-process, such as CSF, may be useful as
optional clinical tool for diagnostic use. However, at the present
time, the access toCSF is limited inour setting for theuseof routine
diagnostic purposes. Therefore, this variable was not included in
our study.
A final possible limitation of the present study is the use of
visual rating scales instead of automated volumetric assessment
of WMH, MTA, and global atrophy. However, studies have shown
high reliability of visual rating scales for assessing WMH and gray
matter atrophy (Wahlund et al., 2000; Gouw et al., 2006; West-
man et al., 2011). These data indicate that visual rating scales
do not underperform compared to volumetric measurements. In
our study, a clear benefit of using visual scales is that it reduces
exclusion based on MRI imaging quality, as volumetric software
is highly sensitive to motion artifacts or small deviations from
scanning protocol as often occur in clinical MRI.
To summarize, this study clearly shows that MTA is associ-
ated with memory, executive function, psychomotor speed, and
global cognitive function, whereas WMH are associated with
global cognition; these effects were independent of global cortical
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atrophy. The relation between morphological abnormalities on
MRI and cognitive deficits will continue to be an important topic
of neuropsychological and neuroimaging research. The recent
development of preventive strategies designed to delay the pro-
gressionof dementia emphasizes the importance of future research
on this subject. These findings set the stage for future studies to
clarify the mechanisms that underlie the dementia process.
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